SeizelT2
Key Info
Basic Information
- Partner:
- Prof. Dr. Jörg B. Schulz
- Faculty / Institution:
- Medicine
- Pillar:
- EIT
- Project duration:
- 01.01.2019 to 31.12.2021
- EU contribution:
- 2.750.000 euros
Title
Discrete personalized epileptic seizure detection device
Concept
SeizeIT2 is a clinically accurate seizure detection system for people with epilepsy. This discrete wearable device monitors several biosignals to allow a more precise quantitative analysis of seizure activity, so that people with epilepsy can receive treatment optimised for their specific condition.
Participants
- UCB Biosciences GmbH, Germany (Coordinator)
- Universitätsklinikum Aachen, Germany
- IESE Business School (CHRIM), Spain
- Karolinska Institutet, Sweden
- Katholieke Universiteit Leuven, Belgium
- UCB Biosciences GmbH, Germany
- Centro Hospitalar e Universitário de Coimbra, EPE, Portugal
- Oxford University Hospitals NHS Foundation Trust, United Kingdom
- Stockholms Läns Landsting, Sweden
This activity has received funding from the European Institute of Innovation and Technology (EIT), a body of the European Union, under the Horizon 2020, the EU Framework Programme for Research and Innovation.